| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Physiological Science*
and Pathology and Laboratory Medicine,
University of California, Los Angeles, California
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The activation of the complement system by the classical or the alternative pathway produces complement fragments that can play important roles in the inflammatory response. For example, leukocyte iC3b receptor CR3 (Mac-1; CD11b/CD18) has been demonstrated to be involved in leukocyte adherence to endothelium via covalent fixation of complement fragment iC3b to endothelium11 whereas C3a and C5a can enhance expression of neutrophil-endothelial cell adhesion receptor, induce vascular leakage, attract leukocytes by chemotaxis,12 and stimulate the release of histamine13 and lytic enzymes in the necrotic area.14 In addition to exerting its biological activity on immunocompetent cells, the complement system can generate the membrane attack complex which involves complement activation and binding of C5b-9 that can lead to a loss in membrane integrity and necrosis of the targeted cells.15 Thus, many of the characteristics of muscle experiencing modified use, such as leukocyte diapedesis,2 muscle membrane defects,16 and necrosis,1 are all consistent with changes expected of complement-mediated events in muscle.
If muscle damage that occurs during reloading results in part from complement activation, then blocking the complement cascade could provide a means to reduce muscle injury during modified muscle use. Numerous strategies have been used in previous investigations to inhibit complement activation that occurs in pathological processes. For example, the depletion of serum complement17 and blockage of complement cascade via injections of recombinant endogenous regulatory proteins18 or through specific antibodies directed against the anaphylatoxin substances C3a and C5a19 have been shown to reduce the accumulation of neutrophils and deposition of complement in ischemic tissue. The truncated, soluble form of complement receptor-1 (sCR1) is the most effective agent for the suppression of ischemia/reperfusion injury in myocardium,18 skeletal muscle,20 and gut21 in which the activation of complement system is particularly well documented after changes in blood flow. The sCR1 retains the ability of the native receptor to bind to activated C3 (C3b) and C4 (C4b) thereby blocking complement activation. Thus, administration of sCR1 to animals before modification of muscle loading could prevent that portion of muscle inflammation and necrosis that is attributable to complement activation.
In this study, we have tested whether the complement system plays a role in inflammatory cell invasion and muscle fiber injury that occurs during muscle loading after a period of unloading by assaying whether sCR1 administration can attenuate muscle injury or inflammation. In addition, we have assessed the pathway through which complement activation occurs during modified muscle use by assaying for changes in the serum concentrations of factor B and C4 which provide indices of the activation of alternative and classical pathways. Inflammation, fiber necrosis, edema, and complement activation were measured after muscle unloading and in animals experiencing muscle reloading for 2, 6, or 24 hours because that time course encompasses that in which extensive inflammation and fiber damage have been shown to occur.2 The results of this study support the hypothesis that the complement system is activated through both the classical and alternative pathways and participates in the recruitment of leukocytes during early stages of increased muscle use.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Adult, 9- to 10-week-old, female Wistar rats were housed individually, maintained on a 12 hour light/dark cycle, and allowed to acclimate to their new environment for a few days. The hindlimbs of the rats were suspended for 10 days by using the technique of Morey-Holton and Wronski.22 Thirty minutes before reloading, experimental and control rats were injected intraperitoneally with sCR1 (20 mg/kg) or an equal volume of phosphate-buffered saline (PBS), respectively. Complement inhibition by sCR1 was maintained in the 24-hour-reloaded group by injecting half doses of sCR1 every 8 hours. Recombinant, endotoxin-free, human sCR1 at a concentration of 3.9 or 4.75 mg/ml in PBS was kindly provided by AVANT Immunotherapeutics, Inc. (Needham, MA). After 10 days of suspension, the animals were removed from the suspension apparatus and allowed to ambulate voluntarily for 0, 2, 6, or 24 hours, designated as the reloading period. All animal treatments followed protocols approved by the University of California, Los Angeles, Animal Research Committee.
Blood Collection and Tissue Preparation
Following the experimental protocol, rats were anesthetized with sodium pentobarbital (50 mg/kg) and blood was obtained by cardiac puncture and collected in a polypropylene tube. After 10 minutes at room temperature, blood samples were centrifuged at 800 x g for 10 minutes and the serum was collected and stored at -70°C. After blood collection, soleus muscles were excised with the tendons intact and maintained near resting length by stapling the tendons to balsa wood coated with a layer of OCT compound. The tissues were then frozen in melting isopentane cooled in liquid nitrogen. Samples were stored at -70°C. Soleus muscles were sectioned at 10 µm, adhered to slides coated with chromium potassium sulfate and gelatin, and stored at -20°C.
Immunohistochemistry
Sections were processed for immunohistochemistry with the following antibodies: 1) anti-ED1+ and anti-ED2+ (diluted 1:100; Bioproducts for Science, Indianapolis, IN) which recognize antigens specific for different subpopulations of monocytes and macrophages; 2) anti-W3/13 (diluted 1:100; Bioproducts for Science) which binds to leukosialin present on neutrophils, monocytes, and T-lymphocytes; and 3) anti-complement C3 (diluted 1:1,000; Cappel Research Products, Durham, NC). Anti-W3/13 is used as a marker for neutrophils in the present investigation because previous studies have shown that neutrophils are the only leukosialin expressing cells to invade muscle in significant numbers in the present model of muscle inflammation.16 The sections were then washed in PBS and incubated with biotinylated anti-mouse or anti-goat IgG (diluted 1:200; Vector Laboratories, Burlingame, CA) for 1 hour at room temperature. After incubation for 2 hours at room temperature in biotinylated second antibody, tissue samples were washed with PBS and incubated with streptavidin-conjugated horseradish peroxidase (1:1,000; Vector Laboratories). After three washes, the antigen-antibody-chromogen complex was developed using a peroxidase substrate kit (AEC; Vector Laboratories). The concentration of inflammatory cells labeled with each antibody was measured in two sections separated by 1 mm in each soleus muscle and examined by light microscopy using Nomarski optics. The number of labeled cells in each section was counted and the total area of the section determined and multiplied by its thickness to express the number of each cell type/mm3.
Quantitation of Fiber Necrosis and Estimation of Muscle Edema
The percentage of total muscle fibers in cross-sections that were invaded by ED1+ cells was determined by light microscopy as an index of muscle necrosis. Tissue edema was measured by observing muscle cross-sections with a microscope equipped with an eyepiece micrometer containing a 10 x 10 sampling grid. Five fields were sampled from each section by counting the percentage of grid sampling points that overlay extracellular tissue, excluding vascular lumina, and that value used as an index of tissue edema. Sample sites were selected randomly, but excluded sites containing sectioning artifacts.
Factor B and C4 Analysis
Factor B is exclusive to the alternative complement pathway and it is commonly used as an indicator of the degree of its activation.23 Factor B concentration was monitored using an assay for hemolysis of sheep red blood cells. Briefly, factor B concentration was determined by mixing the following reagents: 10 µl of factor B deficient serum (Sigma, St. Louis, MO), 5 µl of sheep red blood cells (109 cells/ml; Rockland, Gilbertsville, PA), 1 µl of rat serum, and a volume of gelatin veronal buffer (GVB+) (3.5 mmol/L sodium barbital, 140 mmol/L NaCl, 0.1% gelatin, pH 7.4) containing 20 mmol/L MgCl2 and 80 mmol/L EGTA calculated to give a final reaction volume of 55 µl. After 15 minutes at 37°C with agitation, the reaction was stopped by the addition of 0.5 ml of ice-cold GVB+ and centrifuged at 800 x g to pellet the unlysed erythrocytes. The amount of hemoglobin was estimated by measuring O.D.412. Controls included tubes in which serum was not added to estimate spontaneous lysis, or with water added instead of GVB+ to obtain 100% hemolysis.
C4 analysis was used to test whether the classical pathway was activated during muscle reloading. C4 analysis was based on measurement of lysis of opsonized sheep red blood cells. Opsonization was performed by incubating cells suspended in GVB2+ (3.5 mmol/L sodium barbital, 140 mmol/L NaCl, 0.1% gelatin, pH 7.4, containing 0.15 mmol/L CaCl2, and 0.5 mmol/L MgCl2) with anti-sheep red blood cells for 30 minutes at 37°C. Opsonized red cells (100 µl) were mixed with 5 µl of complement C4-deficient serum from guinea pig (diluted 1:20; Sigma), 20 µl, 40 µl, and 60 µl of experimental rat serum samples (diluted 1:200), and a volume of GVB2+ to give a final reaction volume of 250 µl. The mixture was incubated at 37°C for 30 minutes and the reaction was stopped by adding 0.5 ml of ice-cold GVB2+. Samples were then centrifuged and the hemoglobin released was estimated as described above. Similar to the factor B assay, control tubes were included to estimate spontaneous lysis and 100% hemolysis. For quantification of factor B and C4 concentration, the percentage of hemolysis was determined by expressing the amount of hemolysis obtained from each experimental rat serum relative to 100% hemolysis.
Deposition of Complement C3 on Degenerating Fibers
Bupivacaine was injected in soleus muscle to activate the complement system and initiate deposition of complement C3 on necrotic fibers.8 The muscles were then used as positive controls for C3 immunohistochemistry. Soleus muscles were surgically exposed under generalized anesthesia and 0.2% bupivacaine in PBS was injected in the middle of the muscle belly with a 271/2-gauge needle. The incision was then sutured and covered with wet cotton gauze for 1 hour. After the chemical injury, soleus muscles were dissected and processed for immunohistochemistry analysis as described above.
Statistical Analysis
The values obtained in sCR1-treated animals were compared to the values obtained from PBS-treated animals for all parameters quantified. The significance of differences between groups was tested by one-way analysis of variance (P < 0.05). If significant differences within the experimental treatments were present, groups within the experimental treatment were compared by the Mann-Whitney nonparametric test to locate groups that differed significantly at P < 0.05. Each value for factor B and complement was the average of two independent measurements. Where the error bars are not visible in the figures, this is because of very small error bars.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The sequence of inflammatory and necrotic changes in muscle observed in the present investigation is similar to previous findings,24 although significant changes occurred earlier during reloading in the present study. For example, ED1+ cell concentrations were significantly elevated by 6 hours of reloading in the present study, but were not significantly increased until 24 hours in previous findings.24 ED2+ cell concentrations were elevated at 24 hours reloading in the present investigation, but not until 48 hours in previous work. The advanced course of inflammation in the present investigation may be attributable to the additional animal handling during sCR1 or PBS injections, because animals in the previous study were not subjected to intraperitoneal injections.
The concentration of neutrophils increased significantly in all groups
experiencing reloading when compared to suspended animals (Figures 1 and 2)
.
We confirmed that W3/13+ cells in muscle were
neutrophils by isolating mononucleated cells from reloaded soleus
muscle and then performing indirect immunohistochemistry for W3/13
using the isolated cells. The only W3/13+ cells
isolated from the reloaded solei contained multilobed nuclei
characteristic of neutrophils.
|
|
. Similarly, sCR1
reduced ED1+ cell concentration by 46% at 6
hours of reloading, but did not significantly affect the much larger
increase that was observed at 24 hours of reloading (Figure 3)
. Inhibition of complement by sCR1 was
also apparent in the sCR1-mediated decrease in
ED1+ cell invasion of muscle fibers at 6 hours,
but not at 24 hours of reloading (Figure 4)
. There was no significant increase in
ED2+ cell concentration in either PBS or
sCR1-treated animals at 2 or 6 hours of reloading, compared to animals
experiencing unloading only (Figure 5)
.
However, at 24 hours of reloading, both PBS-treated and sCR1-treated
animals showed elevated concentrations of ED2+
cells in soleus muscles. Administration of sCR1 did not affect the
increase in ED2+ cell concentration that occurred
at 24 hours of reloading. Administration of sCR1 also reduced the
degree of edema (-22%) at 6 hours of reloading, as compared to
PBS-treated controls (Figure 6)
.
|
|
|
|
Complement activation was determined by measuring the
concentration of complement C4 and factor B, which are molecules whose
functions are restricted to the classical and alternative pathways,
respectively. If the complement system is activated, complement C4 and
factor B are proteolytically cleaved and their fragments used as
substrate for the subsequent reaction. Thus, a decrease in
concentration of either factor in the bioassay used here reflects their
cleavage in vivo as the classical or alternative pathway is
activated. Analysis of complement C4 concentration in serum showed that
there was a significant decrease after 2 hours of reloading when
compared to suspended animals, indicating that the classical pathway
was activated during the first hours of reloading. The concentration of
C4 returned to the ambulatory control level after 24 hours of
reloading. The presence of sCR1 in serum (mean concentration, 80.3
µg/ml) abrogated the activation of the classical pathway and reduced
significantly the lysis of sensitized sheep red blood cells (Figure 7)
.
|
. Staining of muscle sections show that
deposition of complement C3 was observed in the positive control
sections in which the soleus muscles were injected with bupivacaine for
1 hour. Complement C3 was also clearly detectable on the surface of
muscle fibers at 2 hours of the reloading, but only faintly detectable
at 24 hours of reloading (Figure 9)
.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The present findings show that muscle use after periods of muscle unloading increases activation of the complement system through both the classical and alternative pathways, and that activation increases muscle inflammation. Two mechanisms are known to be capable of initiating activation of the classical pathway: 1) an antibody-dependent mechanism in which specific immunoglobulins bind antigen and that complex leads to complement activation;28 or 2) an antibody-independent mechanism in which cytosolic particles leaking from necrotic cells react with C1 without requiring antibody-antigen complex formation, which then activates the complement system.29,30 The antibody-dependent mechanism is the best characterized and has been shown to be involved in other models of muscle injury. For example, recombination-activation gene 2-deficient mice, which are totally deficient in antibody, show less muscle injury after ischemia/reperfusion injuries in which complement is normally activated.9 In injuries that result in rapid activation of complement via antibody-dependent mechanisms, it is expected that novel antigenic determinants are presented to pre-existing immunoglobulins9 because activation occurs too rapidly to result from the production of new immunoglobulins to a unknown antigen.31
The antibody-independent mechanism of activation is not well understood but has been demonstrated to occur in other models of muscle injury, such as cardiac ischemia/reperfusion.32 In this case, mitochondrial proteins leaking from the injured cardiac cells can directly or indirectly cause the activation of complement without requiring antibody binding.32 If antibody-independent activation of the classical pathway occurs in the present model system, it implies that some activation molecule is released during the reloading process, although we cannot determine the identity or source of the activating molecule with the present data. However, a potential source would be the muscle fibers that experience increased loading. Mechanical loads have been shown previously to lead to the creation of membrane lesions in muscle that permit the escape of cytosolic molecules into the extracellular space.33 Previous investigations have shown that mitochondrial membrane proteins32 and intermediate filament proteins30 are capable of antibody-independent activation of complement, and both of these types of protein would be present in relatively high concentrations in the reloaded soleus muscles.
The results of this study also show that complement activation contributes to the recruitment of leukocytes to muscle at 6 hours of reloading. Two mechanisms by which complement activation may directly affect leukocyte invasion are by producing substances such as C5a that attract inflammatory cells to the site of injury, or by stimulating the expression of adhesion proteins required for leukocyte diapedesis.34-36 If complement activation occurs through antibody-independent activation of the classical pathway, it would be likely that complement fragments serve a chemotactic role in the inflammation examined here. Because complement will be distributed throughout the extracellular space at relatively high concentrations whereas the putative activating molecule would be present in a concentration gradient that was highest in the reloaded muscle, this would produce a gradient of activated complement and complement fragments that could attract inflammatory cells to the injured muscle. However, this possibility can be confirmed only if the identity of the activating molecule were known.
The possible involvement of complement activation in stimulating diapedesis is also consistent with the reduction in the concentration of inflammatory cells in the muscles of reloaded animals treated with sCR1. For example, C5a or C5b-9 can induce expression of P- and E-selectins, intercellular adhesion molecule-1, and CD11b/CD18 integrin34-38 which can in turn increase diapedesis, but this mechanism of stimulating leukocyte diapedesis would be inhibited by sCR1 treatments. However, other adhesion molecules involved in diapedesis, such as L-selectin and intercellular adhesion molecule-2 are not known to be influenced by complement, which may underlie the ability of some inflammatory cells to invade reloaded muscle even in the presence of sCR1.
The finding that administration of sCR1 reduces muscle edema indicates that complement also plays a role in muscle edema in this model of modified muscle use. Several previous reports support the likelihood that sCR1 inhibition of edema is attributable to blocking C5a production. For example, C5a can induce degranulation of mast cells to increase vascular permeability.39 However, another investigation16 has shown that modified muscle use can result in edema that is not associated with either an increase in mast cell numbers or increased mast cell degranulation. Although it is not known whether mast cell-independent edema is also complement-mediated, it may be partly attributable to direct damage of the vascular endothelium by complement.
In summary, we conclude that: 1) the complement system is activated through both the classical and alternative pathways during modified muscle use; 2) complement inhibition by sCR1 reduces the number of neutrophils and ED1+ macrophages, which suggests that complement fragments are involved in promoting the adhesion and/or migration of leukocytes toward injured muscle; and 3) complement activation contributes to muscle edema and muscle fiber necrosis during modified muscle use.
|
Footnotes |
|---|
Supported by grant NAG5–4837 from NASA.
Accepted for publication March 3, 2000.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  N. Dumont, K. Lepage, C. H. Cote, and J. Frenette Mast cells can modulate leukocyte accumulation and skeletal muscle function following hindlimb unloading J Appl Physiol, July 1, 2007; 103(1): 97 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Tidball and M. Wehling-Henricks Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo J. Physiol., January 1, 2007; 578(1): 327 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. McClung, J. M. Davis, and J. A. Carson Muscle: Ovarian hormone status and skeletal muscle inflammation during recovery from disuse in rats Exp Physiol, January 1, 2007; 92(1): 219 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. McClung, J. M. Davis, M. A. Wilson, E. C. Goldsmith, and J. A. Carson Estrogen status and skeletal muscle recovery from disuse atrophy J Appl Physiol, June 1, 2006; 100(6): 2012 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Bondesen, S. T. Mills, and G. K. Pavlath The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1651 - C1659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Van Gammeren, D. J. Falk, K. C. DeRuisseau, J. E. Sellman, M. Decramer, and S. K. Powers Reloading the Diaphragm Following Mechanical Ventilation Does Not Promote Injury Chest, June 1, 2005; 127(6): 2204 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. McClung, K. A. Mehl, R. W. Thompson, L. L. Lowe, and J. A. Carson Nandrolone decanoate modulates cell cycle regulation in functionally overloaded rat soleus muscle Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1543 - R1552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. X. Nguyen, A. J. Lusis, and J. G. Tidball Null mutation of myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of muscle cell membranes in vitro and in vivo J. Physiol., June 1, 2005; 565(2): 403 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Tidball Inflammatory processes in muscle injury and repair Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R345 - R353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Frenette, N. Chbinou, C. Godbout, D. Marsolais, and P. S. Frenette Macrophages, not neutrophils, infiltrate skeletal muscle in mice deficient in P/E selectins after mechanical reloading Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R727 - R732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Lapointe, J. Frenette, and C. H. Cote Lengthening contraction-induced inflammation is linked to secondary damage but devoid of neutrophil invasion J Appl Physiol, May 1, 2002; 92(5): 1995 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. HUNTER, E. J. STEVENSON, A. KONCAREVIC, H. MITCHELL-FELTON, D. A. ESSIG, and S. C. KANDARIAN Activation of an alternative NF-{kappa}B pathway in skeletal muscle during disuse atrophy FASEB J, April 1, 2002; 16(6): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Frenette, M. St-Pierre, C. H. Cote, E. Mylona, and F. X. Pizza Muscle impairment occurs rapidly and precedes inflammatory cell accumulation after mechanical loading Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R351 - R357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. X. Pizza, T. J. McLoughlin, S. J. McGregor, E. P. Calomeni, and W. T. Gunning Neutrophils injure cultured skeletal myotubes Am J Physiol Cell Physiol, July 1, 2001; 281(1): C335 - C341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. X. Pizza, T. J. Koh, S. J. McGregor, and S. V. Brooks Muscle inflammatory cells after passive stretches, isometric contractions, and lengthening contractions J Appl Physiol, May 1, 2002; 92(5): 1873 - 1878. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
